ClinicalTrials.Veeva

Menu

Comprehensive Assessment of Nutrition and Dietary Intervention in Hypermobile Ehlers Danlos Syndrome (CANDI-hEDS2)

Q

Queen Mary University of London

Status

Completed

Conditions

Irritable Bowel Syndrome
Functional Gastrointestinal Disorders
Hypermobile Ehlers-Danlos Syndrome

Treatments

Behavioral: Dietician advice

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study involves a comprehensive nutritional assessment of hEDS participants who have functional gastrointestinal disorders and dietary intervention to broaden their food choices and nutritional intake.

Full description

The impact of diet on symptoms in patients with Hypermobile Ehlers Danlos Syndrome (hEDS/HSD) is widely recognised yet poorly understood. The investigators aim is to assess existing dietary patterns and nutritional status in hEDS/HSD as well as pilot a personalised dietary strategy to optimise nutrition. Participants recruited from EDS UK and a tertiary Neurogastroenterology clinic at the Royal London Hospital will undergo comprehensive nutritional assessment and blood tests. The investigators will then undertake a feasibility study of personalised dietary intervention in select cohort of patients.

Enrollment

50 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have completed Phase I of the CANDI-hEDS study
  • Diagnosis of hEDS / HSD according to physical examination and history taking
  • Diagnosis of Functional Dyspepsia and / or Irritable Bowel Syndrome according to Rome IV criteria
  • Able and willing to give informed consent
  • Access to video conferencing and a smart phone device
  • Able to travel to the Wingate Institute

Exclusion criteria

  • Dependent upon artificial feeding (parenteral and enteral)
  • Structural gastrointestinal disease
  • Any chronic health condition which already requires a restricted diet e.g. diabetes mellitus
  • Functional vomiting disorder with associated weight loss
  • Multiple Type I hypersensitivity reactions to food groups (i.e. anaphylaxis, urticaria, respiratory symptoms or positive RAST tests).
  • Previous or current severe mental health disorder (e.g. severe depression with suicidal ideation)
  • Previous or current eating disorder
  • Positive screen for avoidant restrictive food intake disorder (ARFID)

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Community cohort
Active Comparator group
Description:
Participants from the Ehlers Danlos UK society community who low diet quality
Treatment:
Behavioral: Dietician advice
Clinic cohort
Active Comparator group
Description:
Participants from a Tertiary Neurogastroenterology clinic who have low die quality
Treatment:
Behavioral: Dietician advice

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems